Search Results For ''

  • RhinoMed secures CVS national distribution of new sleep aid product in the U.S

    Medtech company RhinoMed (ASX: RNO) will soon be significantly increasing its product shelf space in the United States having secured a distribution deal with CVS for its new over-the-counter (OTC) sleep aid product – Pronto Sleep.  With the company forecasting the sleep aids market to reach $66.3 billion by 2021, RhinoMed’s interest focuses on OTC

    Read More
    Public
  • Why free childcare is a hotbed of COVID-19 transmission waiting to kill

    In the same breath of air, Prime Minister Scott Morrison has stressed practices to prevent the community spread of COVID-19 whilst also encouraging parents to utilise a $1.3 billion stimulus package which will make childcare free. It’s clear that Mr Morrison has no idea how childcare centres function.  At a time when Australia faces an

    Read More
    Public
  • Online transactions surge through COVID-19 lockdowns as Novatti acquires Emersion

    As society is bunkered down in self-isolation to prevent the spread of COVID-19, fintech company Novatti (ASX: NOV) has acquired payments platform Emersion with both businesses seeing a rise in online payment processing revenue to accommodate the new contact-free world.  The acquisition will see Emersion integrated into Novatti, bringing with it the $1.7m in revenue

    Read More
    Public
  • Opportunistic scammers use coronavirus to spread computervirus

    Highly publicised tragedies always seem to summon the most despicable of fraudsters. To the rage of many, we saw during the Australian bushfire disaster over 400 fundraiser scams being reported. It appears the coronavirus pandemic is no different, with stories of  phishing emails, fraudulent calls and text messages, and even false claims of vaccine cures.

    Read More
    Public
  • ResApp to launch wireless Sleep Apnoea diagnostics app

    Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch of the SleepCheck smartphone app which has been clinically tested.  Obstructive sleep apnoea (OSA) is one of the most common sleep breathing disorders which affects around 30%of men and 20%of women. However, studies show that

    Read More
    Public
  • Microcap solar farm builder MPower secures $4m contract to build another in S.A.

    Despite trading on the ASX as a microcap, renewable energy company MPower (ASX: MPR) continues to execute a solid pipeline of construction contracts, today announcing the $4 million contract with Astronergy to build a 5MW solar farm in South Australia.  The contract will see MPower execute the engineering, procurement and construction of the solar farm

    Read More
    Public